Navigation Links
Evista Not A Cure For Heart Disease

Evista is the market name of the drug raloxifene HCl is manufactured by drug maker Eli Lilly & Co. a study was conducted which showed that Evista// , a drug used to treat osteoporosis in women, did not prevent heart attacks. The study analyzed 10,000 women in 26 countries for a period of seven years. It was studied whether if this drug given daily for the study period would lower the risks of heart attack and breast cancer in postmenopausal women who either had heart disease or were at high risk for heart attack.

Raloxifene HCl is mainly used to treat and prevent osteoporosis in postmenopausal women. But since this study proved that the drug did not prevent heart attacks the company wanted to reinforce for physicians that Evista should not be prescribed for cardioprotection. Lilly Chief Medical Officer Alan Breier said in a statement that they have gathered new data on Evista's potential to reduce the risk of invasive breast cancer in postmenopausal women. It plans to submit the details of its study to the Food and Drug Administration for review. But further analysis would be needed and precautionary measures to be taken before announcing the use of the drug with respect to breast cancer.
'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Epileptic Seizures Can Be Due to Heart Problem
3. Bypass Heart Surgery Performed Without General Anesthesia
4. New CPR Guidelines issued by Heart Association
5. White Cells Count Can Predict Heart Attack Death Risk
6. Vitamins-The answer to Heart Disease?
7. Fight Heart disease and Pain with Meditation
8. Heart disease in the newborn is related to maternal malnutrition
9. New drug to treat Heart Attack and damaged tissue
10. Heart disease threat starts early in life for Diabetics
11. Mechanical Heart

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Evista Not Cure For Heart Disease

(Date:11/29/2009)...ewswire/ -- The following is an investment opinion..., Inc. ,, Intellivest Securities Research, Inc.... has published a Report on BioClinica, Inc. ( BIOC...otechnology and medical device industries. A prim...ss and submit medical imaging portions of their su...
(Date:11/29/2009)...teach doctors-in-training how to do ultrasound-gui...r skills without compromising patient care and saf...ital. , The study shows that this simulation-bas...ve medical residents, knowledge, dexterity and con...rasound-guided procedures, including breast biopsi...
(Date:11/29/2009).... 29 Acuo Technologies, developers...ware, data migration tools and services, today ann...t allows image sharing across the networks of hosp...re solution is based on the versatile Acuo Technol...AcuoShare enables secure access from various PACS ...
(Date:11/29/2009)...treatment equals a $41,000 pay raise, researchers ...s) -- Psychological therapy may be much more effec...r winning a lottery prize, suggests an English stu... people who provided information about their menta...ess from a $1,329 course of therapy was so signifi...
(Date:11/29/2009)...e YogaForce A-Line Athletic Mat is great. It,s a ..., author and physician best known for establishing...e. Go to www.yogaforce.com and order the new Ma..., San Francisco, CA (PRWEB...ys, the YogaForce newly patented, revolutionary A-...
Breaking Medicine News(10 mins):Health News:Research Report on BioClinica, Inc. as Speculative Buy 2Health News:Simulated training for ultrasound-guided procedures improves safety without risk to patients 2Health News:Acuo Technologies Announces a New Offering That Enables Sharing of Imaging Studies Securely and Affordably 2Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3
... Chairman and Managing Director of Eli Lilly and C...nouncement of a price cut in the company's human i...in product 'Iletin' will be phased out from the ma...f animal insulin products by other drug companies ...
... new generation mums are being plagued by a new ty...y mums. Experts say that though celebrity mums lik...nancy more sexy with cropped tops and clingy dress...o to diet while pregnant, putting their own and th...
...upplemental new drug application (sNDA) for Valtre...the U.S. Food and Drug Administration (FDA) for th...was announced by GlaxoSmithKline which also added ... Cold sores, also known as herpes labialis an...
...article published in an online issue of Nature Med...has reported a stunning discovery of a bold new ty...eir AIDS drugs. The study which was carried// out ...eported that the new vaccine uses a type of cell, ...
...ew study which appeared in the General Dentistry j...right light, loud noise, itchy clothes and strong ...This means// that such a person is likely to avoid...ring, taste and touch, with a notable finding that...
... foundation of diabetics care is the regular monit...many patients do not adhere to this routine becaus... multiple blood samples to be taken by puncturing/... which will end the pain of pricking for diabetes ...
Other Medicine News:
(Date:11/29/2009)..., , CHICAGO, Nov. 29 Resear...(fMRI) to study brain activation have found that m...egative stimuli, according to a study presented to...ety of North America (RSNA). ,, "Men may direct...imuli and tend to process them in terms of implica...
(Date:11/27/2009)..., , Another option to prevent illness..., SILVER SPRING, Md., Nov. 27 /PRNewswire-USNews...ay approved Agriflu for people ages 18 years and o...subtypes A and B. ,, (Logo: http://www.newsc...lu, manufactured by Novartis Vaccines and Diagnost...
(Date:11/27/2009)..., , BLOOMINGTON, Minn, Nov. 27 /PRNewswire/ ...ce medical image management software, data migrati... the United States Patent and Trademark Office has...nication Format within a Computer Network." Acuo T...ts portfolio of intellectual property. In general,...
Breaking Medicine Technology:New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3FDA Approves Agriflu Seasonal Influenza Vaccine 2Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Resident physicians seldom trained in skin cancer examination 59762 1Resident physicians seldom trained in skin cancer examination 59762 2GSA showcases groundbreaking aging research slated for Atlanta meeting 59757 1GSA showcases groundbreaking aging research slated for Atlanta meeting 59757 2GSA showcases groundbreaking aging research slated for Atlanta meeting 59757 3GSA showcases groundbreaking aging research slated for Atlanta meeting 59757 4UD to host conference on Ethics of Climate Change 10413 1UD to host conference on Ethics of Climate Change 10413 2
... Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) anno...n a Phase 1 study to evaluate the safety and,toler...itor of Janus Kinase,3 (JAK3), as a potential trea... psoriasis and other immune disorders. In preclini...ucing arthritic symptoms, bone destruction,and swe...
...SportsCoatings,today announced approximately 10 mi...d with its industry-leading antimicrobial coating,...e feet in 2007., The exponential increase in dema...tors, including a 2007 report in the Journal of th...thicillin-resistant Staphlycoccus,aureas) is respo...
Other Medicine Technology:Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders 2Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders 310 Million Square Feet of Turf Set to be Treated in 2008 in Response to MRSA Outbreaks Nationwide 2
Array Multifocal IOL
MEASLES (Rubeola) IgG IFA TEST
Captia Measles IgM
Measles (Rubeola) IgM ELISA
Medicine Products: